OpenLB
Open Library of Bioscience

Industry influence in evidence production.

Abstract

No abstract text available.

Keywords

References

1. Ann Intern Med. 2008 Apr 1;148(7):544-53 [PMID: 18378949]
2. PLoS Med. 2012;9(8):e1001280 [PMID: 22899894]
3. N Engl J Med. 2004 Oct 21;351(17):1707-9 [PMID: 15470193]
4. BMJ. 2006 May 6;332(7549):1061-4 [PMID: 16547014]
5. J Clin Epidemiol. 2012 May;65(5):535-43 [PMID: 22300677]
6. BMJ. 2009 Jul 20;339:b2680 [PMID: 19622839]
7. BMJ. 2010 Mar 18;340:c1344 [PMID: 20299696]
8. Cochrane Database Syst Rev. 2012 Dec 12;12:MR000033 [PMID: 23235689]
9. BMJ. 2012 Aug 16;345:e5155 [PMID: 22906823]
10. PLoS Med. 2012;9(4):e1001201 [PMID: 22505850]
11. Sci Transl Med. 2012 May 2;4(132):132cm5 [PMID: 22553248]
12. Ann Pharmacother. 2004 Apr;38(4):579-85 [PMID: 14982982]
13. J Clin Epidemiol. 2011 Aug;64(8):830-42 [PMID: 21411286]
14. BMJ. 2009 Dec 08;339:b5164 [PMID: 19995813]
15. Clin Pharmacol Ther. 2012 Apr;91(4):685-91 [PMID: 22378152]
16. PLoS Med. 2008 Sep 23;5(9):e191 [PMID: 18816163]
17. Eur J Clin Invest. 2010 Feb;40(2):172-82 [PMID: 20050879]
18. Ann Intern Med. 2010 Aug 3;153(3):158-66 [PMID: 20679560]
19. JAMA. 2003 Aug 20;290(7):921-8 [PMID: 12928469]

Grants

1. R21 HD072382/United States
2. 1R21HD072382/United States

MeSH Term